Cargando…

Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell Carcinoma

BACKGROUND: There is no universally accepted treatment for patients with advanced papillary renal cell carcinoma (PRCC). The presence of activating mutations in MET, as well as gain of chromosome 7, where the MET gene is located, are the most common genetic alterations associated with PRCC, leading...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pahwa, Roma, Dubhashi, Janhavi, Singh, Anand, Jailwala, Parthav, Lobanov, Alexei, Thomas, Craig J., Ceribelli, Michele, Wilson, Kelli, Ricketts, Christopher J., Vocke, Cathy D., Wells, Catherine, Bottaro, Donald P., Linehan, W. Marston, Neckers, Len, Srinivasan, Ramaprasad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235180/ https://www.ncbi.nlm.nih.gov/pubmed/35754026 http://dx.doi.org/10.1186/s13046-022-02416-z

Ejemplares similares

Targeting loss of the Hippo signaling pathway in NF2-deficient papillary kidney cancers
por: Sourbier, Carole, et al.
Publicado: (2018)

The Mitochondrial HSP90 Paralog TRAP1: Structural Dynamics, Interactome, Role in Metabolic Regulation, and Inhibitors
por: Joshi, Abhinav, et al.
Publicado: (2022)

HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation
por: Kijima, Toshiki, et al.
Publicado: (2018)

Casein kinase 2 phosphorylation of Hsp90 threonine 22 modulates chaperone function and drug sensitivity
por: Mollapour, Mehdi, et al.
Publicado: (2011)

Characterization of genetically defined sporadic and hereditary type 1 papillary renal cell carcinoma cell lines
por: Yang, Youfeng, et al.
Publicado: (2021)

Interaction between Treg Apoptosis Pathways, Treg Function and HLA Risk Evolves during Type 1 Diabetes Pathogenesis
por: Glisic, Sanja, et al.
Publicado: (2012)

Comprehensive characterization of Alu‐mediated breakpoints in germline VHL gene deletions and rearrangements in patients from 71 VHL families
por: Vocke, Cathy D., et al.
Publicado: (2021)

Kidney tumors associated with germline mutations of FH and SDHB show a CpG island methylator phenotype (CIMP)
por: Ricketts, Christopher J., et al.
Publicado: (2022)

Mps1 Mediated Phosphorylation of Hsp90 Confers Renal Cell Carcinoma Sensitivity and Selectivity to Hsp90 Inhibitors
por: Woodford, Mark R., et al.
Publicado: (2016)

Out with the old: Hsp90 finds amino acid residue more useful than co-chaperone protein
por: Zuehlke, Abbey D., et al.
Publicado: (2017)

Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumors
por: Lang, Martin, et al.
Publicado: (2015)

Phosphorylation induced cochaperone unfolding promotes kinase recruitment and client class-specific Hsp90 phosphorylation
por: Bachman, Ashleigh B., et al.
Publicado: (2018)

Hsp90-Dependent Activation of Protein Kinases Is Regulated by Chaperone-Targeted Dephosphorylation of Cdc37
por: Vaughan, Cara K., et al.
Publicado: (2008)

HSP90 inhibitors reduce cholesterol storage in Niemann-Pick type C1 mutant fibroblasts
por: Pipalia, Nina H., et al.
Publicado: (2021)

A germline 1;3 translocation disrupting the VHL gene: a novel genetic cause for von Hippel-Lindau
por: Ricketts, Christopher J, et al.
Publicado: (2022)

An Hsp90 co-chaperone protein in yeast is functionally replaced by site-specific posttranslational modification in humans
por: Zuehlke, Abbey D., et al.
Publicado: (2017)

The mitochondrial HSP90 paralog TRAP1 forms an OXPHOS-regulated tetramer and is involved in mitochondrial metabolic homeostasis
por: Joshi, Abhinav, et al.
Publicado: (2020)

Patient-specific factors influence somatic variation patterns in von Hippel–Lindau disease renal tumours
por: Fei, Suzanne S., et al.
Publicado: (2016)

STA-8666, a novel HSP90 inhibitor/SN-38 drug conjugate, causes complete tumor regression in preclinical mouse models of pediatric sarcoma
por: Heske, Christine M., et al.
Publicado: (2016)

Hsp90 middle domain phosphorylation initiates a complex conformational program to recruit the ATPase-stimulating cochaperone Aha1
por: Xu, Wanping, et al.
Publicado: (2019)

The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance drug binding
por: Woodford, Mark R., et al.
Publicado: (2016)

Gender Specific Mutation Incidence and Survival Associations in Clear Cell Renal Cell Carcinoma (CCRCC)
por: Ricketts, Christopher J., et al.
Publicado: (2015)

Sensitivity of epidermal growth factor receptor and ErbB2 exon 20 insertion mutants to Hsp90 inhibition
por: Xu, W, et al.
Publicado: (2007)

Integration of Gene Dosage and Gene Expression in Non-Small Cell Lung Cancer, Identification of HSP90 as Potential Target
por: Gallegos Ruiz, Mariëlle I., et al.
Publicado: (2008)

Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants
por: Prince, Thomas L., et al.
Publicado: (2015)

Post-translational Regulation of FNIP1 Creates a Rheostat for the Molecular Chaperone Hsp90
por: Sager, Rebecca A., et al.
Publicado: (2019)

Circulating heat shock protein 90 (Hsp90) and autoantibodies to Hsp90 are increased in patients with atopic dermatitis
por: Sitko, Krzysztof, et al.
Publicado: (2021)

Y‐632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo
por: Wang, Wenqian, et al.
Publicado: (2016)

Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments
por: Wei, Darmood, et al.
Publicado: (2020)

Hsp-90 and the biology of nematodes
por: Him, Nik AIIN, et al.
Publicado: (2009)

Mechanisms of Hsp90 regulation
por: Prodromou, Chrisostomos
Publicado: (2016)

Regulatory Mechanisms of Hsp90
por: Prodromou, Chrisostomos
Publicado: (2017)

Inhibitors of HSP90 in melanoma
por: Mielczarek-Lewandowska, Aleksandra, et al.
Publicado: (2019)

Role of HSP90 in Cancer
por: Birbo, Bereket, et al.
Publicado: (2021)

Organismal Roles of Hsp90
por: van Oosten-Hawle, Patricija
Publicado: (2023)

The Distinct Assignments for Hsp90α and Hsp90β: More Than Skin Deep
por: Chang, Cheng, et al.
Publicado: (2023)

Obstructive azoospermia secondary to bilateral epididymal cystadenomas in a patient with von Hippel-Lindau
por: Gomella, Patrick T., et al.
Publicado: (2019)

Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 Cleavage
por: Park, Sangkyu, et al.
Publicado: (2019)

Tumor-Specific Hypermethylation of Epigenetic Biomarkers, Including SFRP1, Predicts for Poorer Survival in Patients from the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) Project
por: Ricketts, Christopher J., et al.
Publicado: (2014)

Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-Myc
por: Sourbier, Carole, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4o3iotl7nlu4aj7br8r1i89i7b